452
Views
12
CrossRef citations to date
0
Altmetric
Review Article

miRNAs in enterovirus infection

, , , &
Pages 701-714 | Received 28 Dec 2017, Accepted 10 Jul 2018, Published online: 14 Aug 2018

References

  • Ajit SK. 2012. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel). 12:3359–3369.
  • Alidjinou EK, Engelmann I, Bossu J, Villenet C, Figeac M, Romond MB, Sane F, Hober D. 2017. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes. Virulence. 8:1229–1244.
  • Alidjinou EK, Sane F, Engelmann I, Geenen V, Hober D. 2014. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov Med. 18:273–282. eng.
  • Baixauli F, Lopez-Otin C, Mittelbrunn M. 2014. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol. 5:403.
  • Baj A, Colombo M, Headley JL, McFarlane JR, Liethof MA, Toniolo A. 2015. Post-poliomyelitis syndrome as a possible viral disease. Int J Infect Dis. 35:107–116.
  • Bao JL, Lin L.2014. MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-kappaB pathway during acute viral myocarditis. Eur Rev Med Pharmacol Sci. 18:2349–2356.
  • Berkhout B, Haasnoot J. 2006. The interplay between virus infection and the cellular RNA interference machinery. FEBS Lett. 580:2896–2902.
  • Bian L, Wang Y, Liu Q, Xia J, Long JE. 2015. Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes. Arch Virol. 160:173–182.
  • Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, Dolken L, Pfeffer S. 2010. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA. 16:307–315.
  • Chang YL, Ho BC, Sher S, Yu SL, Yang PC. 2015. miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45beta. Cell Microbiol. 17:802–818.
  • Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science. 260:1338–1343.
  • Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol. 74:10153–10164.
  • Chen ZG, Liu H, Zhang JB, Zhang SL, Zhao LH, Liang WQ. 2015. Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection. Mol Med Rep. 12:1258–1264.
  • Correia CN, Nalpas NC, McLoughlin KE, Browne JA, Gordon SV, MacHugh DE, Shaughnessy RG. 2017. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol. 8:118.
  • Corsten MF, Papageorgiou A, Verhesen W, Carai P, Lindow M, Obad S, Summer G, Coort SL, Hazebroek M, van Leeuwen R, et al. 2012. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res. 111:415–425.
  • Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z, Wu T, Shan J, Shan Y, Zhu Z, et al. 2010. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol. 2010:425939.
  • Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X, Guo X, Shi Z, Zhou M, Zhu B, et al. 2011. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One. 6:e27071.
  • Cullen BR. 2006. Viruses and microRNAs. Nat Genet. 38(Suppl):S25–S30.
  • de Crom SC, Rossen JW, van Furth AM, Obihara CC. 2016. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 175:1023–1029.
  • Du X, Wang H, Xu F, Huang Y, Liu Z, Liu T. 2015. Enterovirus 71 induces apoptosis of SHSY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep. 12:953–959.
  • Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D. 2017. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells. Cell Mol Life Sci. 74:3851–3861. eng.
  • Esquela-Kerscher A, Slack FJ. 2006. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
  • Etheridge A, Lee I, Hood L, Galas D, Wang K. 2011. Extracellular microRNA: a new source of biomarkers. Mutat Res. 717:85–90.
  • Fu Y, Xu W, Chen D, Feng C, Zhang L, Wang X, Lv X, Zheng N, Jin Y, Wu Z. 2015. Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral Res. 124:43–53.
  • Fu Y, Zhang L, Zhang F, Tang T, Zhou Q, Feng C, Jin Y, Wu Z. 2017. Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. PLoS Pathog. 13:e1006611.
  • Fung G, Luo H, Qiu Y, Yang D, McManus B. 2016. Myocarditis. Circ Res. 118:496–514.
  • Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 10:629–653.
  • Gutkoska J, LaRocco M, Ramirez-Medina E, de Los Santos T, Lawrence P. 2017. Host microRNA-203a Is antagonistic to the progression of foot-and-mouth disease virus infection. Virology. 504:52–62.
  • Haasnoot J, Berkhout B. 2011. RNAi and cellular miRNAs in infections by mammalian viruses. Methods Mol Biol. 721:23–41.
  • Harvala H, Broberg E, Benschop K, Berginc N, Ladhani S, Susi P, Christiansen C, McKenna J, Allen D, Makiello P, et al. 2018. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 101:11–17.
  • He J, Yue Y, Dong C, Xiong S. 2013. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. Clin Invest Med. 36:E103–E111.
  • Hemida MG, Ye X, Zhang HM, Hanson PJ, Liu Z, McManus BM, Yang D. 2013. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Cell Mol Life Sci. 70:277–291.
  • Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, Singh S, Kao CL, Chen HY, Su KY, et al. 2011. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 9:58–69.
  • Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY, Tsai CW, Chang YL, Wu CT, Chang LY, Shih SR, et al. 2014. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 5:3344.
  • Hober D, Alidjinou EK. 2013. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr Opin Infect Dis. 26:263–269.
  • Hober D, Sané F, Riedweg K, Moumna I, Goffard A, Choteau L, Alidjinou EK, Desailloud R. 2013. Viruses and type 1 diabetes: focus on the enteroviruses. In: Escher AP, Li A, editors. Type 1 diabetes.Rijeka, Croatia: Intech Editions
  • Hober D, Sauter P. 2010. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol. 6:279–289.
  • Hu Y, Song J, Liu L, Li J, Tang B, Wang J, Zhang X, Zhang Y, Wang L, Liao Y, et al. 2016. Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from high-throughput sequencing in rhesus monkey peripheral blood mononuclear cells. Int J Biochem Cell Biol. 81:20–31.
  • Hu Y, Song J, Liu L, Li J, Tang B, Zhang Y, Wang J, Wang L, Fan S, Feng M, et al. 2017. Comparison analysis of microRNAs in response to EV71 and CA16 infection in human bronchial epithelial cells by high-throughput sequencing to reveal differential infective mechanisms. Virus Res. 228:90–101.
  • Huang JY, Chou SF, Lee JW, Chen HL, Chen CM, Tao MH, Shih C. 2015. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ. RNA. 21:385–400.
  • Jaidane H, Caloone D, Lobert PE, Sane F, Dardenne O, Naquet P, Gharbi J, Aouni M, Geenen V, Hober D. 2012. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J Virol. 86:11151–11162.
  • Jaidane H, Sane F, Gharbi J, Aouni M, Romond MB, Hober D. 2009. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev. 25:591–603.
  • Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. 2013. Treatment of HCV infection by targeting microRNA. N Engl J Med. 368:1685–1694.
  • Jia HL, He CH, Wang ZY, Xu YF, Yin GQ, Mao LJ, Liu CW, Deng L. 2014. MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis. 14:506.
  • Jin J, Li R, Jiang C, Zhang R, Ge X, Liang F, Sheng X, Dai W, Chen M, Wu J, et al. 2017. Transcriptome analysis reveals dynamic changes in coxsackievirus A16 infected HEK 293T cells. BMC Genomics. 18:933.
  • Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 309:1577–1581.
  • Kim KW, Ho A, Alshabee-Akil A, Hardikar AA, Kay TW, Rawlinson WD, Craig ME. 2016. Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets. Diabetes. 65:996–1003.
  • Kuehl U, Lassner D, Gast M, Stroux A, Rohde M, Siegismund C, Wang X, Escher F, Gross M, Skurk C, et al. 2015. Differential cardiac microRNA Expression predicts the clinical course in human enterovirus cardiomyopathy. Circ Heart Fail. 8:605–618.
  • Lam WY, Cheung AC, Tung CK, Yeung AC, Ngai KL, Lui VW, Chan PK, Tsui SK. 2015. miR-466 is putative negative regulator of coxsackie virus and adenovirus receptor. FEBS Lett. 589:246–254.
  • Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327:198–201.
  • Lawrence P, Schafer EA, Rieder E. 2012. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology. 425:40–52.
  • Li Y, Xie J, Xu X, Wang J, Ao F, Wan Y, Zhu Y. 2013. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1. Protein Cell. 4:130–141.
  • Liu X, Wang T, Wakita T, Yang W. 2010. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology. 398:57–67.
  • Liu YL, Wu W, Xue Y, Gao M, Yan Y, Kong Q, Pang Y, Yang F. 2013. MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch Virol. 158:1953–1963.
  • Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. 2008. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol. 82:10436–10443.
  • Lui YL, Tan TL, Woo WH, Timms P, Hafner LM, Tan KH, Tan EL. 2014. Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS One. 9:e102997.
  • Orr-Burks NL, Shim BS, Wu W, Bakre AA, Karpilow J, Tripp RA. 2017. MicroRNA screening identifies miR-134 as a regulator of poliovirus and enterovirus 71 infection. Sci Data. 4:170023.
  • Pierre S, Bats AS, Coumoul X. 2011. Understanding SOS (Son of Sevenless). Biochem Pharmacol. 82:1049–1056.
  • Rai DK, Lawrence P, Kloc A, Schafer E, Rieder E. 2015. Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections. Virol J. 12:224.
  • Reid G, Kirschner MB, van Zandwijk N. 2011. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 80:193–208.
  • Rose NR. 2016. Viral myocarditis. Curr Opin Rheumatol. 28:383–389.
  • Salvador JM, Brown-Clay JD, Fornace AJ. Jr. 2013. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol. 793:1–19.
  • Sanchez-Jimenez F, Sanchez-Margalet V. 2013. Role of Sam68 in post-transcriptional gene regulation. IJMS. 14:23402–23419.
  • Sane F, Caloone D, Gmyr V, Engelmann I, Belaich S, Kerr-Conte J, Pattou F, Desailloud R, Hober D. 2013. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol Life Sci. 70:4169–4180.
  • Shim BS, Wu W, Kyriakis CS, Bakre A, Jorquera PA, Perwitasari O, Tripp RA. 2016. MicroRNA-555 has potent antiviral properties against poliovirus. J Gen Virol. 97:659–668.
  • Song J, Hu Y, Li J, Zheng H, Wang J, Guo L, Ning R, Li H, Yang Z, Fan H, et al. 2017. Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing. PLoS One. 12:e0177657.
  • Sun S, Ma J, Zhang Q, Wang Q, Zhou L, Bai F, Hu H, Chang P, Yu J, Gao B. 2016. Argonaute proteins in cardiac tissue contribute to the heart injury during viral myocarditis. Cardiovasc Pathol. 25:120–126.
  • Tang WF, Huang RT, Chien KY, Huang JY, Lau KS, Jheng JR, Chiu CH, Wu TY, Chen CY, Horng JT. 2016. Host MicroRNA miR-197 plays a negative regulatory role in the enterovirus 71 infectious cycle by targeting the RAN protein. J Virol. 90:1424–1438.
  • Tapparel C, Siegrist F, Petty TJ, Kaiser L. 2013. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol. 14:282–293.
  • Tong L, Lin L, Wu S, Guo Z, Wang T, Qin Y, Wang R, Zhong X, Wu X, Wang Y, et al. 2013. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 41:3760–3771.
  • Umbach JL, Cullen BR. 2009. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 23:1151–1164.
  • Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, et al. 2012. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res. 93:270–279.
  • Wang RY, Weng KF, Huang YC, Chen CJ. 2016. Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections. Sci Rep. 6:24149.
  • Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. 2010. The microRNA spectrum in 12 body fluids. Clin Chem. 56:1733–1741.
  • Wen BP, Dai HJ, Yang YH, Zhuang Y, Sheng R. 2013. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 56:195–200.
  • WHO R. 2011. A Guide to clinical management and public health response for hand, foot and mouth disease (HFMD). World Health Organization Regional Office for the Western Pacific. ISBN 978 92 9061 525 5.
  • Xu C, He X, Zheng Z, Zhang Z, Wei C, Guan K, Hou L, Zhang B, Zhu L, Cao Y, et al. 2014. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J Virol. 88:11356–11368.
  • Xu HF, Ding YJ, Shen YW, Xue AM, Xu HM, Luo CL, Li BX, Liu YL, Zhao ZQ. 2012. MicroRNA- 1 represses Cx43 expression in viral myocarditis. Mol Cell Biochem. 362:141–148.
  • Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ. 2014. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep. 10:161–168.
  • Xu LJ, Jiang T, Zhao W, Han JF, Liu J, Deng YQ, Zhu SY, Li YX, Nian QG, Zhang Y, et al. 2014. Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS One. 9:e95272.
  • Xun M, Ma CF, Du QL, Ji YH, Xu JR. 2015. Differential expression of miRNAs in enterovirus 71-infected cells. Virol J. 12:56.
  • Yang X, Xie J, Jia L, Liu N, Liang Y, Wu F, Liang B, Li Y, Wang J, Sheng C, et al. 2017. Analysis of miRNAs involved in mouse brain damage upon enterovirus 71 infection. Front Cell Infect Microbiol. 7:133.
  • Ye X, Hemida MG, Qiu Y, Hanson PJ, Zhang HM, Yang D. 2013. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/β-catenin signal pathways. Cell Mol Life Sci. 70:4631–4644.
  • Ye X, Liu Z, Hemida MG, Yang D. 2011. Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA. PLoS One. 6:e21215.
  • Ye X, Zhang HM, Qiu Y, Hanson PJ, Hemida MG, Wei W, Hoodless PA, Chu F, Yang D. 2014. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog. 10:e1004070.
  • Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ, Lindberg AM, Pallansch MA, Palmenberg AC, Reuter G, et al. 2017. ICTV virus taxonomy profile: picornaviridae. J Gen Virol. 98:2421–2422.
  • Zhang G, Wang J, Yao G, Shi B. 2017. Downregulation of CCL2 induced by the upregulation of microRNA-206 is associated with the severity of HEV71 encephalitis. Mol Med Rep. 16:4620–4626.
  • Zhang L, Chen X, Shi Y, Zhou B, Du C, Liu Y, Han S, Yin J, Peng B, He X, et al. 2014. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes. 49:373–382.
  • Zhang Q, Xiao Z, He F, Zou J, Wu S, Liu Z. 2013. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology. 56:104–113.
  • Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H. 2013. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol. 87:5645–5656.
  • Zhou B, Chu M, Xu S, Chen X, Liu Y, Wang Z, Zhang F, Han S, Yin J, Peng B, et al. 2017. Hsa-let-7c-5p augments enterovirus 71 replication through viral subversion of cell signaling in rhabdomyosarcoma cells. Cell Biosci. 7:7.
  • Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et al. 2014. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 370:818–828.
  • Zhu Z, Qi Y, Fan H, Cui L, Shi Z. 2016. Systematic identification and bioinformatic analysis of microRNAs in response to infections of coxsackievirus a16 and enterovirus 71. Biomed Res Int. 2016:4302470.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.